6The potential of a sustained release formulation for paracetamol produced by melt pelletisation was investigated. After the production of the pellets, based on the combination of stearic acid as a melting binder and anhydrous lactose as a filler, the 3000–2000 μm size fraction was selected in the light of the promising in vitro dissolution results for further characterisations, including scanning electron microscopy (SEM), X-ray photoelectron spectroscopy (XPS), specific surface area and true density determination. Hence the release mechanism was analysed with the help of an appropriate mathematical model. The mathematical model was built on the hypotheses that drug diffusion and solid drug dissolution in the release environment are ...
Objective: To characterise a novel multifunctional pharmaceutical excipient and investigate its effe...
Paracetamol/Eudragit RS, paracetamol/ethylcellulose, and paracetamol/cellulose acetate pellets of di...
The progress from batch to continuous manufacture of pharmaceuticals has highlighted the requirement...
The potential of a sustained release formulation for paracetamol produced by melt pelletisation was ...
The potential of a sustained release formulation for paracetamol produced by melt pelletisation was ...
The potential of a sustained release formulation for paracetamol produced by melt pelletisation was ...
The potential of a sustained release formulation for paracetamol produced by melt pelletisation was ...
Objective: To study the effects of three formulation variables (PVP, stearic acid and Avicel PH101) ...
The purpose of this study is to evaluate the possibility of developing a cylindrical sustained-relea...
The aims of this study were to evaluate the dissolution performance of solid dosage forms using the ...
With the purpose of evaluating the behavior of different polymers employed as binders in small-diame...
This study was conducted to develop and characterize a hot melt co-extruded cylindrical system for c...
Drug dissolution and release characteristics from freeze-dried wafers and solvent-cast films prepare...
Objective - A process of melt granulation whereby the drug powder is mixed with a melted wax has bee...
ABSTRACT: Ten brands of commercial paracetamol suspensions were investigated for their dissolution c...
Objective: To characterise a novel multifunctional pharmaceutical excipient and investigate its effe...
Paracetamol/Eudragit RS, paracetamol/ethylcellulose, and paracetamol/cellulose acetate pellets of di...
The progress from batch to continuous manufacture of pharmaceuticals has highlighted the requirement...
The potential of a sustained release formulation for paracetamol produced by melt pelletisation was ...
The potential of a sustained release formulation for paracetamol produced by melt pelletisation was ...
The potential of a sustained release formulation for paracetamol produced by melt pelletisation was ...
The potential of a sustained release formulation for paracetamol produced by melt pelletisation was ...
Objective: To study the effects of three formulation variables (PVP, stearic acid and Avicel PH101) ...
The purpose of this study is to evaluate the possibility of developing a cylindrical sustained-relea...
The aims of this study were to evaluate the dissolution performance of solid dosage forms using the ...
With the purpose of evaluating the behavior of different polymers employed as binders in small-diame...
This study was conducted to develop and characterize a hot melt co-extruded cylindrical system for c...
Drug dissolution and release characteristics from freeze-dried wafers and solvent-cast films prepare...
Objective - A process of melt granulation whereby the drug powder is mixed with a melted wax has bee...
ABSTRACT: Ten brands of commercial paracetamol suspensions were investigated for their dissolution c...
Objective: To characterise a novel multifunctional pharmaceutical excipient and investigate its effe...
Paracetamol/Eudragit RS, paracetamol/ethylcellulose, and paracetamol/cellulose acetate pellets of di...
The progress from batch to continuous manufacture of pharmaceuticals has highlighted the requirement...